Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dingli

Showing results (161-170 of 471) with videos related to

Pageof 48
Sort By:
Bone Marrow Transplantation|April 5, 2025
Outcomes of attenuated dose fludarabine and melphalan based conditioning regimen in patients undergoing allogeneic stem cell transplant: a propensity score-matched analysisAnmol Baranwal, Rabee Kassis, Khalil Hassan, et al.
American Journal of Hematology|October 1, 2011
Hematopoietic recovery kinetics predicts for poor CD34+ cell mobilization after cyclophosphamide chemotherapy in multiple myelomaGuner Hayri Ozsan, Ivana N Micallef, Angela Dispenzieri, et al.
American Journal of Hematology|September 4, 2025
Risk of Relapse Post Reduced Intensity Conditioning Allogeneic Stem Cell Transplant in Patients With High-Risk Myeloid Neoplasms Based on GvHD Prophylaxis: PTCy Vs. TAC/MTXKhalil Hassan, Anmol Baranwal, Al Rabee Kassis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2018
Stem Cell Transplantation for Light Chain Amyloidosis: Decreased Early Mortality Over TimeM Hasib Sidiqi, Mohammed A Aljama, Francis K Buadi, et al.
Mayo Clinic Proceedings|January 7, 2014
Biomedical system dynamics to improve anemia control with darbepoetin alfa in long-term hemodialysis patientsJames T McCarthy, Craig L Hocum, Robert C Albright, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 14, 2018
Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?Eli Muchtar, Morie A Gertz, Shaji K Kumar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 12, 2018
Autologous Stem Cell Transplant for IgM-Associated Amyloid Light-Chain AmyloidosisM Hasib Sidiqi, Francis K Buadi, Angela Dispenzieri, et al.
Blood|July 19, 2013
Implications of continued response after autologous stem cell transplantation for multiple myelomaWilson I Gonsalves, Morie A Gertz, Angela Dispenzieri, et al.
American Journal of Hematology|June 12, 2016
Proteasome inhibitor associated thrombotic microangiopathyJennifer C Yui, Jan Van Keer, Brendan M Weiss, et al.
Research Square|November 14, 2023
Mode of Progression in Smoldering Multiple Myeloma: A study of 406 patientsS Rajkumar, Nadine Abdallah, Arjun Lakshman, et al.
Pageof 48

Showing results (161-170 of 471) with videos related to

Sort By:
Pageof 48
Bone Marrow Transplantation|April 5, 2025
Outcomes of attenuated dose fludarabine and melphalan based conditioning regimen in patients undergoing allogeneic stem cell transplant: a propensity score-matched analysisAnmol Baranwal, Rabee Kassis, Khalil Hassan, et al.
American Journal of Hematology|October 1, 2011
Hematopoietic recovery kinetics predicts for poor CD34+ cell mobilization after cyclophosphamide chemotherapy in multiple myelomaGuner Hayri Ozsan, Ivana N Micallef, Angela Dispenzieri, et al.
American Journal of Hematology|September 4, 2025
Risk of Relapse Post Reduced Intensity Conditioning Allogeneic Stem Cell Transplant in Patients With High-Risk Myeloid Neoplasms Based on GvHD Prophylaxis: PTCy Vs. TAC/MTXKhalil Hassan, Anmol Baranwal, Al Rabee Kassis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2018
Stem Cell Transplantation for Light Chain Amyloidosis: Decreased Early Mortality Over TimeM Hasib Sidiqi, Mohammed A Aljama, Francis K Buadi, et al.
Mayo Clinic Proceedings|January 7, 2014
Biomedical system dynamics to improve anemia control with darbepoetin alfa in long-term hemodialysis patientsJames T McCarthy, Craig L Hocum, Robert C Albright, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 14, 2018
Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?Eli Muchtar, Morie A Gertz, Shaji K Kumar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 12, 2018
Autologous Stem Cell Transplant for IgM-Associated Amyloid Light-Chain AmyloidosisM Hasib Sidiqi, Francis K Buadi, Angela Dispenzieri, et al.
Blood|July 19, 2013
Implications of continued response after autologous stem cell transplantation for multiple myelomaWilson I Gonsalves, Morie A Gertz, Angela Dispenzieri, et al.
American Journal of Hematology|June 12, 2016
Proteasome inhibitor associated thrombotic microangiopathyJennifer C Yui, Jan Van Keer, Brendan M Weiss, et al.
Research Square|November 14, 2023
Mode of Progression in Smoldering Multiple Myeloma: A study of 406 patientsS Rajkumar, Nadine Abdallah, Arjun Lakshman, et al.
Pageof 48